Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study

Artac, M.Cubukcu, E.Bozkurt, O.Bilici, A.Celik, S.Ozcelik, M.Oven, B.2024-08-042024-08-0420220923-75341569-8041https://doi.org/10.1016/j.annonc.2022.04.182https://hdl.handle.net/11616/103984ESMO 24th World Congress on Gastrointestinal Cancer -- JUN 29-JUL 02, 2022 -- Barcelona, SPAIN[Abstract Not Available]eninfo:eu-repo/semantics/openAccess[No Keywords]Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey studyConference Object33S281S28210.1016/j.annonc.2022.04.182WOS:000823826500105Q1